Drx Choice Maximum Strength Severe Solution
NDC Package 68163-749-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Drx Choice Maximum Strength Severe (acetaminophen, dextromethorphan hbr) solution is ▪do not take more than 6 doses in any 24-hour period▪do not exceed recommended dosage. This formulation utilizes a solution delivery system. Marketed by Raritan Pharmaceuticals, this product is identified by NDC 68163-749 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
68163-749-08
Package Description
1 BOTTLE in 1 CARTON / 237 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
68163074908
RxNorm Crosswalk
  • RxCUI: 1919076 - acetaminophen 325 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution
  • RxCUI: 1919076 - acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Solution
  • RxCUI: 1919076 - acetaminophen 325 MG / dextromethorphan HBr 10 MG per 10 mL Oral Solution
  • RxCUI: 1919076 - acetaminophen 650 MG / dextromethorphan HBr 20 MG per 20 mL Oral Solution
  • RxCUI: 1919076 - APAP 32.5 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML Oral Solution

Clinical Specifications

Proprietary Name
Drx Choice Maximum Strength Severe Cough Plus Sore Throat
Non-Proprietary Name
Acetaminophen, Dextromethorphan Hbr
Substance Name
Acetaminophen; Dextromethorphan Hydrobromide
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
▪do not take more than 6 doses in any 24-hour period▪do not exceed recommended dosage. Taking more than the recommended dose (overdose) may cause serious liver damage.▪measure only with dosing cup provided▪keep dosing cup with product▪mL = milliliter▪this adult product is not intended for use in children under 12 years of ageAgedoseadults and children 12 years and over20 mL every 4 hourschildren under 12 yearsdo not use

Regulatory & Marketing

Labeler Name
Raritan Pharmaceuticals
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-24-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68163-749-08 identifies a specific commercial package of 1 bottle in 1 carton / 237 ml in 1 bottle of Drx Choice Maximum Strength Severe Cough Plus Sore Throat, a human over the counter drug labeled by Raritan Pharmaceuticals. This solution is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Raritan Pharmaceuticals on April 24, 2023. The current certification is valid through December 31, 2026.

How is this Raritan Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68163074908. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68163-749-08
11-Digit CMS (5-4-2)
68163-0749-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.